Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Longitudinal Studies01:26

Longitudinal Studies

247
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
247
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

286
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
286
Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Crossover Experiments01:16

Crossover Experiments

3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

264
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
264

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Risk Substance and Polysubstance Use Among Elective Surgery Patients: Prevalence and Risk Factors.

Journal of the American College of Surgeons·2026
Same author

Adaptive intervention strategies for malaria vector control in western Kenya: a cluster, sequential, multiple-assignment, randomised, open-label trial.

The Lancet. Global health·2026
Same author

Feasibility Pilot Trial for the Trajectories of Recovery after Intravenous Propofol versus Inhaled Volatile Anesthesia (THRIVE) Pragmatic Randomized Clinical Trial.

Anesthesiology·2026
Same author

Bayesian randomized basket trial design: a case study from the ultra-rare invasive mold infections.

Biometrics·2026
Same author

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

JAMA otolaryngology-- head & neck surgery·2025
Same author

SMARTs with treatment preference: Pragmatic SMART design and methods motivated by STAR*D.

Contemporary clinical trials·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Sep 11, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K

Evaluating longitudinal treatment effects for Duchenne muscular dystrophy using dynamically enriched Bayesian small

Sidi Wang1, Satrajit Roychoudhury2, Kelley M Kidwell1

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, United States.

Biometrics
|August 12, 2025
PubMed
Summary
This summary is machine-generated.

New statistical methods enhance rare disease clinical trials for Duchenne muscular dystrophy (DMD). This approach uses sequential multiple assignment randomized trials (snSMART) and external data to improve treatment effect analysis.

Keywords:
Bayesian hierarchical modelDuchenne muscular dystrophyclinical triallongitudinal studiesrare disease

More Related Videos

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.9K

Related Experiment Videos

Last Updated: Sep 11, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.9K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Rare Disease Research

Background:

  • Progressive rare diseases like Duchenne muscular dystrophy (DMD) present unique challenges in evaluating treatment efficacy due to small patient populations and disease heterogeneity.
  • Traditional clinical trial designs struggle to capture the full spectrum of disease burden and treatment impact over time in such conditions.
  • The scarcity of participants and ethical considerations in rare disease research necessitate innovative approaches to trial design and data analysis.

Purpose of the Study:

  • To introduce and apply novel statistical methodologies for analyzing longitudinal data from sequential, multiple assignment, randomized trials (snSMART) in rare diseases.
  • To demonstrate the utility of integrating external control data to enhance statistical and operational efficiency in rare disease drug development.
  • To address challenges related to patient heterogeneity and stage-wise treatment assignments in clinical trials.

Main Methods:

  • Development of new statistical approaches for analyzing data from snSMART trials, specifically tailored for small sample sizes.
  • Implementation of a two-step robust meta-analytic approach to effectively leverage external control data.
  • Adjustment for baseline confounders and potential conflicts between external and trial data, integration of baseline covariates, and a novel piecewise model for stage-wise treatment assignments.

Main Results:

  • The proposed methodology was successfully applied to a case study in Duchenne muscular dystrophy research.
  • Demonstrated the practical application and benefits of the advanced statistical approach in analyzing complex trial data.
  • Highlighted the potential of the methodology to mitigate common challenges encountered in rare disease clinical trials.

Conclusions:

  • The developed statistical framework offers a more nuanced and robust analysis of treatment effects in rare disease trials.
  • Integrating external control data and advanced modeling techniques can significantly improve the reliability and efficiency of clinical trial results.
  • This approach holds promise for advancing drug development and improving the evaluation of disease burden in progressive rare conditions like DMD.